Transaction · 0001493152-26-026269

Pershing Edward

Pershing Edward, CEO, reported a transaction classified as grant at PROVECTUS BIOPHARMACEUTICALS, INC.. A 10b5-1 reference was not detected in the stored filing text.

grantSEC transaction code ACEO
PVCTPROVECTUS BIOPHARMACEUTICALS, INC.
Trade date
May 28, 2026
Filing date
May 29, 2026
View on SEC Insider profile
Estimated value—Shares × reported price
Shares traded—$0.00 per share
Holdings after—Direct
% of reported position tradedUnavailableThis security and ownership context
How reported position traded is calculated

Not calculated for derivative securities.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Filing warnings

Notes recorded with this filing
1 warning
missing sharesThe filing did not provide usable transaction shares.

PVCT price since this filing

Daily closing prices, with the filing date and available return windows
PVCT · Daily closing priceLoading daily prices…
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago1w ago1d ago
Returns since7d30d90d180d1y

Transaction facts

Stored Form 4 columns with their raw values

Derivative
Type
grant
Code A
Identifier
0001493152-26-026269
8% Unsecured Convertible Promissory Note
Transaction date
May 28, 2026
Filed May 29, 2026, 05:22 PM · 1d delay
Shares
—
$0.00 per share
Estimated value
—
Computed from shares × price
Holdings after
—
Direct

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $100kLarge $1.00M
Derivative Transaction Direct Ownership
Filing-only score

-14 points

Compact filing score computed from stored Form 4 facts. Version v1.

Mixed or weak signal

This filing has a negative filing-only score. It may be less informative as an insider-activity signal and needs extra context.

How this score is calculated
  • direct_ownership+6 points

    direct_or_indirect_ownership = D

    Direct ownership reports the insider's personal stake.
  • timely_filing+4 points

    reporting_delay_days = 1

    Filing reported within two business days of the transaction.
  • derivative_transaction-16 points

    is_derivative = true

    Derivative exercise rows are less discretionary than open-market purchases.
  • missing_shares-8 points

    shares is null

    Missing shares reduces confidence in value-based signals.
Missing facts
  • shares
Read the scoring methodology

Signed filing-only points, not a probability or expected return. Version v1.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

CEO

Officer YesDirector Yes10% NoOther No
Footnotes & amended
  1. F1

    The Reporting Person may voluntarily elect to convert the outstanding principal and interest of the 8% unsecured convertible promissory note (the "Note") at any time while the Note is outstanding into…

  2. F2

    Each share of Series D-1 Preferred Stock is convertible into 10 shares of the Issuer's common stock, par value $0.001 per share ("Common Stock"). The Series D-1 Preferred Stock will automatically conv…

Original filing · 0001493152-26-026269
Related transactions

0 other transactions

Same SEC filing
Recent company activity

0 recent txs

PVCT